A Study of JNT-517 in Participants With Phenylketonuria (PKU)

NCT06971731 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Phenylketonuria

Interventions

DRUG: JNT-517 Tablet
DRUG: JNT-517 Tablet
DRUG: Placebo Tablet: BID

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.